Clinical Trials in San Francisco

Showing 7421-7440 of 12,991 trials

Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer

NCT00006360

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of radiation therapy in treating patients who have stage II or stage III oropharyngeal cancer.

Head and Neck CancerRadiation Toxicity

Radiation Therapy Oncology GroupStarted Feb 2001

Phoenix, Arizona, United States • San Francisco, California, United States • Gainesville, Florida, United States +15 more locations

COMPLETEDPhase 2< 1 mile

Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum

NCT00006366

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known which regimen of radiation therapy plus chemotherapy is more effective for rectal cancer. PURPOSE: Randomized phase II trial to compare two regimens of radiation therapy plus chemotherapy followed by surgery in treating patients who have locally advanced cancer of the rectum.

Colorectal Cancer

Radiation Therapy Oncology GroupStarted Feb 2001

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Huntsville, Alabama, United States +232 more locations

Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer

Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum

Find Trials by Condition in San Francisco

One Week Aligner Evaluation

Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer

Intraoperative Pleth Variability Index (PVI) Variability

Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy

Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors

In-Home Evaluation of Episodic Administration of Palovarotene in Fibrodysplasia Ossificans Progressiva (FOP) Subjects

Safety and Biomarker Study of EPI-589 in Participants With Amyotrophic Lateral Sclerosis (ALS)

National Marrow Donor Program Long-Term Donor Follow-Up

Extension Study of Ataluren (PTC124) in Cystic Fibrosis

KPI-121 1% Versus Prednisolone for the Treatment of Inflammation Following Cataract Surgery in Children

A Study for Participants With Relapsed Cutaneous T-Cell Lymphoma

TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)

Randomized Phase 2 Trial of Axitinib and TRC105 Versus Axitinib Alone in Patients Renal Cell Carcinoma

Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer

A Study of ARRY-371797 in Patients With Active Ankylosing Spondylitis

Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study

Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas

A Study of ARRY-334543 in Patients With Advanced Cancer